| Tier-4 customers fund the 2027 capex step-up that the growth score rests on, rather than pushing equipment deliveries right | ||
| Gross margin expansion continues; the 13-consecutive-quarter streak of YoY expansion does not break | ||
| AMAT holds or extends its conductor etch share gain and does not lose core deposition share to Lam | ||
| AGS operating margin holds at or near 30%, preserving the annuity that floors the bear leg | ||
| China export-licence restrictions do not tighten further onto AMAT's shippable WFE portfolio | ||
| Capex declines as a percentage of revenue as guided, so FCF conversion improves |
Consensus is Buy with 42 of 53 analysts at buy-or-better and a 675.65 target implying +33.7%. My probability-weighted expectation is +17.2%. I do not disagree with the street's growth path — I anchor the base case to it | high |
The revision tape is UNAVAILABLE, not neutral: eps_drift and rev_drift both return n_up 0, n_down 0, breadth 0.0, direction flat, median_move_pct null over a 365-day window. So the independent cross-check on whether cons | high |
Consensus disagrees with itself where my thesis lives. FY2027 revenue dispersion is 23.5% across 26 estimates and FY2028 is 39.6% across 20, versus 0.4% for FY2025. The point estimate for the exact period my scenarios tu | high |
My quality score of 8 rests partly on AMAT's +300bp conductor etch share gain, while third-party technical research states Lam is dominating molybdenum deposition and taking share FROM AMAT tungsten tools. Both are true | medium |
No signal desk exists to agree or disagree with. Four of the five cross-checks the system is designed to run against an analyst view are structurally unavailable, and no options-implied probability was obtainable for eit | medium |
| archived | hash | bytes |
|---|---|---|
| 2026-08-19T08:32:01 | 4e74d6ed8ac7 | 27,036 |